CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity.
Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤微环境(TME)在癌症进展中起着关键作用,其中癌症相关成纤维细胞(CAFs)已成为免疫逃逸的关键参与者。本综述探讨了CAFs与树突状细胞(DCs)之间复杂的相互作用,DCs是激活免疫反应所必需的抗原呈递细胞。CAFs通过分泌细胞因子、趋化因子和生长因子,损害DC的成熟和功能,降低其呈递抗原和刺激T细胞的能力,从而促进有利于肿瘤生长的免疫抑制环境。此外,CAFs促进耐受性DCs的分化,进而培育出进一步抑制抗肿瘤免疫的调节性T细胞(Tregs)。本综述审视了CAF-DC crosstalk的分子机制,并讨论了旨在恢复DC功能的潜在治疗策略。靶向CAF驱动的免疫抑制网络为增强基于DC的疫苗和免疫疗法的疗效提供了有前景的机会,为改善癌症治疗结果铺平了道路。
The tumor microenvironment (TME) plays a critical role in cancer progression, with cancer-associated fibroblasts (CAFs) emerging as key players in immune evasion. This review explores the complex interactions between CAFs and dendritic cells (DCs), essential antigen-presenting cells that activate immune responses. CAFs impair DC maturation and function by secreting cytokines, chemokines, and growth factors, reducing their ability to present antigens and stimulate T cells, thus promoting an immunosuppressive environment favorable to tumor growth.
Additionally, CAFs contribute to the differentiation of tolerogenic DCs, fostering regulatory T cells (Tregs) that further suppress antitumor immunity. This review examines the molecular mechanisms underlying CAF-DC crosstalk and discusses potential therapeutic strategies aimed at restoring DC functionality. Targeting the CAF-driven immunosuppressive network offers promising opportunities to enhance the efficacy of DC-based vaccines and immunotherapies, paving the way for improved cancer treatment outcomes.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。